Amgen (United States)

Amgen (United States)

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Amgen (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

45%


Total
Publications

15K


Total Open
Publications

6.7K


Total
Citations

791K


Open Access
Percentage

45%


Total
Publications

15K


Total Open
Publications

6.7K


Total
Citations

791K

Wikipedia

Website

download

Breakdown

22% 18% 4% 56%

Publisher Open

22%

Both

18%

Other Platform Open

4%

Closed

56%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0100200300400500600700800Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

1.7K

Hybrid 38%

2.2K

No Guarantees 33%

1.9K

Other Platform Open

Domain 74%

2.5K

Institution 24%

808

Other Internet 21%

706

Public 4%

129

Preprint 0%

9

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
2.5K
DOI
Other Internet
582
Europe PMC
Domain
152
Unknown Repository
Other Internet
141
DANS - Data Archiving and Networked Services
Institution
126
Figshare
Public
120
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
52
Elsevier - Scopus
Institution
49
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
42
Konstfack University of Arts, Crafts, and Design - Publications
Institution
35
1 / 20

Data updated 18 August 2025

Share

Share

Share